PROGYNY, INC. (PGNY) News
Filter PGNY News Items
PGNY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PGNY News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest PGNY News From Around the Web
Below are the latest news stories about PROGYNY INC that investors may wish to consider to help them evaluate PGNY as an investment opportunity.
Progyny Stock Saw Big Buys From the CEO and a Former CEOCEO Peter Anevski and Executive Chairman David Schlanger bought a total of $5.2 million of stock of fertility-benefits firm Progyny. |
Progyny CEO & Director Acquires 136% More StockThose following along with Progyny, Inc. ( NASDAQ:PGNY ) will no doubt be intrigued by the recent purchase of shares by... |
Progyny, Inc. (PGNY): A Bull Case TheoryWe came across a bullish thesis on Progyny, Inc. (NASDAQ:PGNY) on Directionally Correct Research’s Substack by Will Powers. In this article, we will summarize the bulls’ thesis on PGNY. Progyny, Inc. (NASDAQ:PGNY)’s share was trading at $14.71 as of Dec 26th. PGNY’s trailing and forward P/E were 24.52 and 9.37 respectively according to Yahoo Finance. Progyny, Inc. […] |
What Does Progyny, Inc.'s (NASDAQ:PGNY) Share Price Indicate?Progyny, Inc. ( NASDAQ:PGNY ), might not be a large cap stock, but it saw significant share price movement during... |
Here’s What Led to a Sharp Drop in Progyny’s (PGNY) Share PriceFred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S. equities performed well in the third quarter of 2024, with the S&P 500 rising 5.89%. Utilities and Real Estate sectors outperformed relative to the index while […] |
Meridian Hedged Equity Fund Decided to Sell its Holdings in Progyny (PGNY). Here’s WhyMeridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The significant move by the FED to cut the interest rate helped the market to stabilize. In the quarter, the fund appreciated 6.19% (net), outperforming its benchmark, the S&P […] |
Here’s Why Progyny (PGNY) Was Under Pressure in Q3Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The third quarter had a strong finish for U.S. small-cap equities, driven by interest rate reductions and fading recessionary concerns. In the third quarter, the fund delivered 7.65% […] |
Progyny, Inc. to Present at Jefferies London Healthcare ConferenceNEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 8:00 a.m. GMT (3:00 a.m. EST). A live audiocast and replay will be available from the Events and Presentations |
Progyny Third Quarter 2024 Earnings: Misses ExpectationsProgyny ( NASDAQ:PGNY ) Third Quarter 2024 Results Key Financial Results Revenue: US$286.6m (up 2.0% from 3Q 2023). Net... |
Progyny price target lowered to $21 from $22 at BofABofA lowered the firm’s price target on Progyny (PGNY) to $21 from $22 and keeps a Buy rating on the shares. Q3 results highlight ongoing pressure from an unfavorable utilization mix, with limited line of sight into when such dynamics may change, but while the firm acknowledges that utilization trends create some uncertainty, overall it remains optimistic on the fertility end-market and Progyny’s market leading position, the analyst tells investors. Published first on TheFly – the ultimate sourc |